WATCHMAN Implantation During Hybrid Ablation "WINNING"


Phase N/A Results N/A

Summary of Purpose

Atrial fibrillation (AF) is the most common cardiac arrhythmia with a lifetime risk of developing AF of 1 in 4 people aged over 40. Stroke remains the most feared complication of AF with an increase in risk by 5-fold, and is the leading cause of morbidity and mortality. The left atrial appendage (LAA) is the origin for more than 90% of the emboli in non-valvular AF. The WATCHMANâ„¢ Left Atrial Closure Device...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 September 2016.

1 Oct 2015 20 May 2015 1 Oct 2016 1 Feb 2017 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Intervention: Single Group Assignment